Search results for "Tricuspid Valve Insufficiency"

showing 10 items of 25 documents

Transgastric imaging-The key to successful periprocedural TEE guiding for edge-to-edge repair of the tricuspid valve.

2021

Intraprocedural transesophageal echocardiography (TEE) guidance plays an essential role in transcatheter repair therapy of the tricuspid valve (TV). So far, several different imaging concepts are in use. We propose an imaging protocol that fully addresses the morphological complexity of the TV and further offers efficacious workarounds for the frequently occurring restrictions of TV imaging in edge-to-edge repair of the TV. As a tertiary referral center with a large experience of more than 250 cases of transcatheter edge-to-edge repair (TEER) of the TV performed at the Heart Valve Center in Mainz/Germany, we have constantly adapted our peri-interventional echocardiographic approach to accom…

Heart Valve Prosthesis Implantationmedicine.medical_specialtyCardiac CatheterizationTricuspid valvebusiness.industryInterventional imagingTricuspid Valve Insufficiencymedicine.anatomical_structureEchocardiographymedicineKey (cryptography)Referral centerHumansRadiology Nuclear Medicine and imagingRadiologyEnhanced Data Rates for GSM EvolutionHeart valveTricuspid ValveCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealEchocardiography (Mount Kisco, N.Y.)REFERENCES
researchProduct

12‐Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation

2021

Objectives We investigated the durability of tricuspid regurgitation (TR) reduction and the clinical outcomes through 12 months after transcatheter tricuspid valve repair (TTVr) with the PASCAL Transcatheter Valve Repair System. Background TTVr has rapidly developed and demonstrated favorable acute outcomes, but longer follow-up data are needed. Methods Overall, 30 patients (age 77 ± 6 years; 57% female) received PASCAL implantation from September 2017 to May 2019 and completed a clinical follow-up at 12 months. Results The TR etiology was functional in 25 patients (83%), degenerative in three (10%), and mixed in two (7%). All patients had TR severe or greater (massive or torrential in 80%)…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsRegurgitation (circulation)030204 cardiovascular system & hematologytranscatheter tricuspid valve intervention PASCAL 12-month outcomes severe tricuspid regurgitation right-sided heart failure03 medical and health sciences0302 clinical medicinemedicineHumansEndocarditisRadiology Nuclear Medicine and imagingddc:610030212 general & internal medicineTRICUSPID VALVE REPAIRStrokeSurvival rateAgedAged 80 and overHeart Valve Prosthesis Implantationbusiness.industryPascal (unit)General Medicinemedicine.diseaseTricuspid Valve InsufficiencySurgeryTreatment OutcomeHeart failureEtiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Value of Echocardiographic Right Ventricular and Pulmonary Pressure Assessment in Predicting Transcatheter Tricuspid Repair Outcome

2020

The aim of this study was to assess the value of echocardiographic right ventricular (RV) and systolic pulmonary artery pressure (sPAP) assessment in predicting transcatheter tricuspid edge-to-edge valve repair (TTVR) outcome.RV dysfunction and pulmonary hypertension are associated with poor prognosis and are systematically sought during tricuspid regurgitation evaluation. The value of echocardiographic assessment in predicting TTVR outcome is unknown.Data were taken from the TriValve (Transcatheter Tricuspid Valve Therapies) registry, which includes patients undergoing TTVR at 14 European and North American centers. The primary outcome was 1-year survival free from hospitalization for hear…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsRegurgitation (circulation)Pulmonary Artery030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicinePrimary outcomePredictive Value of TestsInternal medicinemedicine.arteryVentricular PressureHumansMedicineArterial PressureProspective StudiesRegistries030212 general & internal medicineAgedAged 80 and overHeart FailureHospital readmissionTricuspid valvebusiness.industryRecovery of FunctionMiddle Agedmedicine.diseasePulmonary hypertensionTricuspid Valve Insufficiency3. Good healthPulmonary pressureEuropeTreatment Outcomemedicine.anatomical_structureEchocardiographyHeart failureNorth AmericaPulmonary arteryDisease ProgressionVentricular Function RightCardiologyFemaleCardiology and Cardiovascular MedicinebusinessJACC: Cardiovascular Interventions
researchProduct

Refractory congestive heart failure: when the solution is outside the heart

2020

Abstract Refractory congestive heart failure is associated with an ominous prognosis in which the treatments strategies remain scarce and not well validated. In the last years, continuous ambulatory peritoneal dialysis (CAPD) has emerged as a therapeutic alternative in this subset of patients. So far, it has been associated with a significant improvement in functional capacity and quality of life, together with a striking reduction in the risk of readmissions. We present the case of an elderly patient with severe left ventricular dysfunction and severe mitral and tricuspid regurgitation who presents recurrent admissions for anasarca. After its inclusion in a CAPD programme, the patient expe…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtymedicine.medical_treatmentPeritoneal dialysisCase ReportRegurgitation (circulation)030204 cardiovascular system & hematologyAnasarcaVentricular Function LeftPeritoneal dialysis03 medical and health sciences0302 clinical medicinePeritoneal Dialysis Continuous AmbulatoryQuality of lifeRefractoryInternal medicinemedicineHumans030212 general & internal medicineAgedHeart Failurebusiness.industryContinuous ambulatory peritoneal dialysismedicine.diseaseTricuspid Valve InsufficiencyTreatmentRefractory congestive heart failureEchocardiographylcsh:RC666-701Heart failureQuality of LifeCardiologymedicine.symptomDiureticCardiology and Cardiovascular MedicinebusinessESC Heart Failure
researchProduct

Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.

2020

This study was designed to assess hemodynamic changes in response to transcatheter tricuspid valve edge-to-edge repair (TTVR) and to identify hemodynamic predictors associated with mortality.Severe tricuspid regurgitation (TR) is associated with high mortality. TTVR effectively alleviates heart failure symptoms, but comprehensive hemodynamic characterization of patients undergoing TTVR is currently lacking.This international, multicenter study included 236 patients undergoing TTVR. Data from clinical assessment, echocardiography, intraprocedural right heart catheterization, and noninvasive cardiac output measurement were analyzed. Hemodynamic predictors for mortality were identified using l…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsHemodynamicsRegurgitation (circulation)030204 cardiovascular system & hematologyNew york heart association03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineTRICUSPID VALVE REPAIRAgedHeart FailureHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryProportional hazards modelHemodynamicsRecovery of Functionmedicine.diseaseTricuspid Valve Insufficiencymedicine.anatomical_structureTreatment OutcomeMulticenter studyHeart failureCardiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessJACC. Cardiovascular interventions
researchProduct

Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation.

2018

BACKGROUND Pulmonary hypertension (PH) is a common cause of right ventricular (RV) remodeling and functional tricuspid regurgitation (FTR), but incremental pulmonary artery systolic pressure (PASP) does not always correlate with anatomic and functional RV changes. This study aimed to evaluate a noninvasive measure of pulmonary vascular resistance (PVR) for predicting RV dilatation, RV dysfunction, and severity of FTR. METHODS We prospectively analyzed consecutive stable patients with PASP ≥ 35 mm Hg or any degree of RV dilatation or dysfunction secondary to PH. Noninvasive PVR was calculated based on FTR peak velocity and flow in RV outflow tract. RESULTS We included 251 patients, aged 72.1…

Malemedicine.medical_specialtyHeart Ventricles030204 cardiovascular system & hematologyDoppler echocardiographyPulmonary ArteryInferior vena cavaSeverity of Illness Index03 medical and health sciences0302 clinical medicineFunctional tricuspid regurgitationmedicine.arteryInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingArterial PressureProspective StudiesVentricular remodelingAgedmedicine.diagnostic_testVentricular Remodelingbusiness.industrymedicine.diseasePulmonary hypertensioneye diseasesTricuspid Valve InsufficiencyBlood pressuremedicine.anatomical_structure030228 respiratory systemmedicine.veinEchocardiographyPulmonary arteryCardiologyVascular resistanceFemaleVascular Resistancesense organsCardiology and Cardiovascular MedicinebusinessEchocardiography (Mount Kisco, N.Y.)
researchProduct

CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.

2019

In acute heart failure (AHF) with right ventricular dysfunction, the roles of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) are poorly understood, and functional tricuspid regurgitation (TR) severity is thought to indicate a poor prognosis. We examined the prognostic abilities of NT-proBNP and CA125 according to TR status among patients with AHF.TR severity was assessed during index hospitalization (108 ± 24 h after admission) and classified as none/trivial, mild, moderate, or severe. Multivariable Cox regression analysis was performed to assess how pre-discharge CA125 and NT-proBNP were associated with long-term all-cause mortality relative t…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classRegurgitation (circulation)030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseases030212 general & internal medicineAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryMembrane ProteinsStroke VolumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsTricuspid Valve InsufficiencyHeart failureCA-125 AntigenCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicineIndex hospitalizationbusinessBiomarkersInternational journal of cardiology
researchProduct

Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure.

2015

BACKGROUND Tricuspid regurgitation (TR) is a common echocardiographic finding that has been related to adverse outcome under various clinical scenarios. Nevertheless, evidence supporting its prognostic value in heart failure (HF) is scarce, and, in most cases, contradictory. We evaluated the association of TR grade with 1-year all-cause mortality in acute HF (AHF). METHODS AND RESULTS: We included 1,842 consecutive patients admitted for AHF. Mean age was 72.8±11.3 years, 51% were female and 45.5% had LVEF <50%. The severity of TR was graded in non-TR, mild (1), moderate (2), moderate-severe (3) and severe (4). At 1-year follow-up, 370 patients (20.1%) had died. In patients with LVEF ≥50%, a…

Malemedicine.medical_specialtySystolic functionRegurgitation (circulation)Ventricular Function LeftRisk FactorsInternal medicinemedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overHeart FailureEjection fractionbusiness.industryHazard ratioMean ageGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalTricuspid Valve InsufficiencyEchocardiographyHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesCirculation journal : official journal of the Japanese Circulation Society
researchProduct

Shedding some light on tricuspid intervention

2021

Background More than 1.6 million Americans have at least moderate to severe valvular tricuspid regurgitation, yet fewer than 8000 tricuspid valve operations are performed annually in the USA. The undertreatment for isolated tricuspid regurgitation might be related to the fact that in the past years no clear guidelines on 'how' and 'when' to treat tricuspid regurgitation were issued. Aims Sarris-Michopoulos and colleagues carried out a meta-analysis with the aim to investigate the role of tricuspid valve repair versus tricuspid valve replacement in patients with isolated tricuspid valve regurgitation. Material and methods Outcomes of patients with first-time surgery for isolated tricuspid va…

Pulmonary and Respiratory MedicineModerate to severecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPercutaneousContext (language use)Regurgitation (circulation)Intervention (counseling)Internal medicineHumansMedicinecardiovascular diseasesRetrospective StudiesHeart Valve Prosthesis ImplantationTricuspid valvebusiness.industryTricuspid Valve InsufficiencySurgeryTreatment Outcomemedicine.anatomical_structureVentricleCohortcardiovascular systemCardiologySurgeryTricuspid ValveTricuspid Valve RegurgitationCardiology and Cardiovascular Medicinebusiness
researchProduct

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

2022

Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. The aim of this study was to analyze the causes of post-transplant TR and its effect on overall mortality.Methods: This is a retrospective observational study of all transplants performed in two Spanish centers (1009 patients) between 2000 and 2019. Of the total number of patients, 809 had no TR or mild TR and 200 had moderate or severe TR. The etiology of TR was analyzed in all cases.Results: The prevalence of moderate and severe TR was 19.8%. The risk of mortality was greater …

TransplantationSurvivalIncidenceTricuspid regurgitationHeart transplantationPrognosisSeverity of Illness IndexTricuspid Valve Insufficiency*aetiologyTreatment Outcome*heart transplantation*tricuspid regurgitation*prognosisHumansHeart Transplantation*survivalAetiologyRetrospective StudiesTransplant international : official journal of the European Society for Organ Transplantation
researchProduct